BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12091353)

  • 1. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid.
    Pan XQ; Zheng X; Shi G; Wang H; Ratnam M; Lee RJ
    Blood; 2002 Jul; 100(2):594-602. PubMed ID: 12091353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acid.
    Li H; Lu Y; Piao L; Wu J; Liu S; Marcucci G; Ratnam M; Lee RJ
    Int J Pharm; 2010 Dec; 402(1-2):57-63. PubMed ID: 20883757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
    Qi H; Ratnam M
    Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells.
    Lu Y; Wu J; Wu J; Gonit M; Yang X; Lee A; Xiang G; Li H; Liu S; Marcucci G; Ratnam M; Lee RJ
    Mol Pharm; 2007; 4(5):707-12. PubMed ID: 17708654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model.
    Pan XQ; Wang H; Lee RJ
    Pharm Res; 2003 Mar; 20(3):417-22. PubMed ID: 12669962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model.
    Pan XQ; Lee RJ
    Anticancer Res; 2005; 25(1A):343-6. PubMed ID: 15816557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the folate receptor type beta gene by coordinate actions of retinoic acid receptors at activator Sp1/ets and repressor AP-1 sites.
    Hao H; Qi H; Ratnam M
    Blood; 2003 Jun; 101(11):4551-60. PubMed ID: 12543860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor induction and targeted drug delivery: a new antileukaemia strategy.
    Ratnam M; Hao H; Zheng X; Wang H; Qi H; Lee R; Pan X
    Expert Opin Biol Ther; 2003 Jul; 3(4):563-74. PubMed ID: 12831362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia.
    Wang H; Zheng X; Behm FG; Ratnam M
    Blood; 2000 Nov; 96(10):3529-36. PubMed ID: 11071651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant GPI structure in relation to membrane-associated functions of a murine folate receptor.
    Wang X; Jansen G; Fan J; Kohler WJ; Ross JF; Schornagel J; Ratnam M
    Biochemistry; 1996 Dec; 35(50):16305-12. PubMed ID: 8973205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
    Xiang G; Wu J; Lu Y; Liu Z; Lee RJ
    Int J Pharm; 2008 May; 356(1-2):29-36. PubMed ID: 18258394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-trans retinoic acid is capable of inducing folate receptor β expression in KG-1 cells.
    Xu Y; Wang T; Tang R; Tang S
    Tumour Biol; 2010 Dec; 31(6):589-95. PubMed ID: 20632143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate receptor targeted delivery of liposomal daunorubicin into tumor cells.
    Ni S; Stephenson SM; Lee RJ
    Anticancer Res; 2002; 22(4):2131-5. PubMed ID: 12174894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted drug delivery via folate receptors.
    Zhao X; Li H; Lee RJ
    Expert Opin Drug Deliv; 2008 Mar; 5(3):309-19. PubMed ID: 18318652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity.
    Shen F; Ross JF; Wang X; Ratnam M
    Biochemistry; 1994 Feb; 33(5):1209-15. PubMed ID: 8110752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.
    Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A
    Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro.
    Lee RJ; Low PS
    Biochim Biophys Acta; 1995 Feb; 1233(2):134-44. PubMed ID: 7865538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia.
    Ross JF; Wang H; Behm FG; Mathew P; Wu M; Booth R; Ratnam M
    Cancer; 1999 Jan; 85(2):348-57. PubMed ID: 10023702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-Trans Retinoic Acid and Doxorubicin Delivery by Folic Acid Modified Polymeric Micelles for the Modulation of Pin1-Mediated DOX-Induced Breast Cancer Stemness and Metastasis.
    Liu Y; Yu F; Dai S; Meng T; Zhu Y; Qiu G; Wen L; Zhou X; Yuan H; Hu F
    Mol Pharm; 2021 Nov; 18(11):3966-3978. PubMed ID: 34579532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.